Nuria Ariza-Jordana
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Characterization of a rare EGFR resistance mutation in a lung cancer patient with a long response to osimertinib: case report.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 15, 2026
Impact of TP53, KEAP1 and STK11 mutations in localized-stage NSCLC: A European thoracic oncology platform lungscape project.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 04, 2025
Vaccine antibodies against a synthetic epidermal growth factor variant enhance the antitumor effects of inhibitors targeting the MAPK/ERK and PI3K/Akt pathways.
Journal: Translational oncology
Published: October 30, 2023
Overcoming MET-mediated resistance in oncogene-driven NSCLC.
Journal: iScience
Published: March 15, 2023
Effect of Osimertinib on CTCs and ctDNA in EGFR Mutant Non-Small Cell Lung Cancer Patients: The Prognostic Relevance of Liquid Biopsy.
Journal: Cancers
Published: January 31, 2022
The EPICAL trial, a phase Ib study combining first line afatinib with anti-EGF vaccination in EGFR-mutant metastatic NSCLC.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 15, 2021
RNA-Based Multiplexing Assay for Routine Testing of Fusion and Splicing Variants in Cytological Samples of NSCLC Patients.
Journal: Diagnostics (Basel, Switzerland)
Published: November 05, 2020
Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform.
Journal: Clinical chemistry
Published: May 12, 2020
Evolution and Clinical Impact of EGFR Mutations in Circulating Free DNA in the BELIEF Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 13, 2019
Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions.
Journal: Molecular oncology
Published: May 14, 2019
Prospective analysis of liquid biopsies of advanced non-small cell lung cancer patients after progression to targeted therapies using GeneReader NGS platform.
Journal: Translational cancer research
Published: October 03, 2018
Early evolution of BRAFV600 status in the blood of melanoma patients correlates with clinical outcome and identifies patients refractory to therapy.
Journal: Melanoma research
Published: February 27, 2018
Last Updated: 09/26/2026